SCHEMBL29288482

SCHEMBL29288482

O=C(Cl)COCc1ccc(Cl)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.49
CA2 P00918 2/20 0.49
CA9 Q16790 2/20 0.49
IDO1 P14902 2/20 0.47
AGXT P21549 2/20 0.47
NR4A2 P43354 2/20 0.46
ALDH1A1 P00352 1/20 0.46
GRM5 P41594 3/20 0.46
RAB9A P51151 4/20 0.45
MMP2 P08253 1/20 0.45
MAOA P21397 1/20 0.45
MAOB P27338 1/20 0.45
NPC1 O15118 2/20 0.44
KMT2A Q03164 2/20 0.43
USP2 O75604 1/20 0.42
GAA P10253 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1759771 0.84 NR4A2 (0.50) CA1CA2CA9IDO1AGXT
SCHEMBL7222950 0.82 RXRA (0.45) ALDH1A1RAB9ANPC1KMT2AUSP2
SCHEMBL9358412 0.82 MAOA (0.51) CA1CA2CA9IDO1AGXT
SCHEMBL7221565 0.82 RAB9A (0.50) CA1CA2CA9AGXTALDH1A1
SCHEMBL5282539 0.82 IDO1 (0.45) IDO1AGXTNR4A2GRM5MMP2
SCHEMBL7664334 0.82 ADAMTS5 (0.52) NR4A2ALDH1A1GRM5RAB9ANPC1
SCHEMBL73270 0.82 ALDH1A1 (0.59) ALDH1A1GRM5RAB9ANPC1KMT2A
SCHEMBL30984464 0.81 CA1 (0.46) CA1CA2CA9IDO1AGXT
SCHEMBL11334466 0.79 PPARG (0.54) CA1CA2CA9IDO1AGXT
SCHEMBL30984468 0.79 CA1 (0.45) CA1CA2CA9IDO1AGXT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109400489-A Preparation method of meclofenoxate hydrochloride 广东华南药业集团有限公司 2019-03-01 CN claimed
CN-109400489-A Preparation method of meclofenoxate hydrochloride 广东华南药业集团有限公司 2019-03-01 CN disclosed